Podcast: Play in new window | Download (Duration: 12:14 — 11.2MB) | Embed
On this episode, I discuss the new medication vonoprazan and where it will likely be used in practice.
Vonoprazan is from a brand new class of medication called “PCAB”. I discuss this medication and its pharmacology in this podcast episode.
Drug interactions and cost are the two major downsides of this medication that will likely limit its use compared to the PPIs.
CYP3A4 inducers like rifampin, carbamazepine, and phenytoin should not be used with vonoprazan. They will reduce the effectiveness of vonoprazan.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Support The Podcast and Check Out These Amazing Resources!
Flippin’ Pharmacology Flash Cards
Pharmacology Crossword Puzzle Book (Over 2,000 Clues/Questions!)
Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)
Guide to Drug Food Interactions (Amazon Best Seller)
Drug Interactions In Primary Care (Amazing Resource for Practicing Clinicians)
Perils of Polypharmacy (Great Resource for Those Who Work in Geriatrics)